PROCLAIM : résultats finaux de survie globale de l’essai de phase III : pemetrexed cisplatine ou étoposide cisplatine, plus radiothérapie thoracique suivie d’une chimiothérapie de consolidation dans le CBNPC non épidermoïde localement avancé
Year: 2015
Type: article
Study design: Clinical Trial
Source: Revue des Maladies Respiratoires
Institutions: Amsterdam UMC Location Vrije Universiteit Amsterdam, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, Centre Oscar Lambret, Princess Margaret Cancer Centre, Chinese Academy of Medical Sciences & Peking Union Medical College, Universitair Ziekenhuis Leuven, KU Leuven, Cancer Center of Kansas, Jeroen Bosch Ziekenhuis, Complejo Hospitalario de Navarra, Erasmus MC, Washington University in St. Louis, Hospital Universitario Quirónsalud Madrid, Charing Cross Hospital, UC Davis Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Chinese University of Hong Kong, Eli Lilly (United States), Eli Lilly (Canada)
Language: French
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2209510506